Intellipharmaceutics International Inc. filed its Annual on Jun 05, 2023 for the period ending Nov 30, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 CAD | -.--% | -11.11% | +6.67% |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 1.93M | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.58% | 239B | |
+7.45% | 204B | |
-8.38% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- IPCI.H Stock
- News Intellipharmaceutics International Inc.
- Intellipharmaceutics International Inc. Auditor Raises 'Going Concern' Doubt